Posts by: Patricia Inacio PhD

Impaired activity of the adrenal glands, a condition called Addison’s disease, may be the only typical manifestation of autoimmune polyglandular syndrome type 1 (APS1) to have occurred decades after diagnosis, ... Read more

January 17, 2022January 17, 2022

Men Talk About Hemophilia’s Toll, Gaps in Care in Canadian Study

Hemophilia News Today

A hemophilia diagnosis takes a toll on the social and mental health of men, who often feel misunderstood and excluded from activities such as sports, a Canadian interview-based study reports. ... Read more

January 17, 2022January 17, 2022

Pilot Trial of FGF-1 to Promote Blood Vessel Growth in Brain Planned

Parkinson's News Today

Zhittya Genesis Medicine plans to launch what it is calling a “Compassionate Use Clinical Trial” of FGF-1, a biological compound aiming to stimulate new blood vessel growth in the brain, for ... Read more

January 14, 2022January 14, 2022

Nova Mentis, Mycrodose Team Up to Test Skin Patch Delivery of Psilocybin

Fragile X News Today

Nova Mentis and Mycrodose Therapeutics have teamed up to test whether psychedelic treatments, such as Nova’s psilocybin — a potential behavioral therapy for fragile X syndrome — can be delivered ... Read more

January 14, 2022January 14, 2022

Pain With Dominant DEB Can Be Severe, Affecting Life Quality

Epidermolysis Bullosa News

Pain, but not wound size, significantly affects a person’s perception of disease severity with dominant dystrophic epidermolysis bullosa (DEB), a study reports. Chronic open wounds, difficulty swallowing or walking, and ... Read more

January 14, 2022January 14, 2022

Satisfaction and Interest Strong for Remote Trials, Study Finds

COVID-19 News, Parkinson's News Today

People who took part in remote, video-conducted clinical trials for Parkinson’s disease reported high levels of satisfaction and interest in participating in future studies with remote video visits, scientists report. ... Read more

January 13, 2022January 13, 2022

Trial of Cell Therapy to Raise HbF Levels Showing Potential, But Sanofi Leaving

Sickle Cell Disease News

Sangamo Therapeutics is assuming all rights to SAR445136, an investigational gene-edited cell therapy co-developed with Sanofi and now in a Phase 1/2 trial in adults with severe sickle cell disease (SCD). Early trial ... Read more

January 13, 2022January 13, 2022

Atara, Imeka Team Up to Bring Advanced Imaging to ATA188 Trial

Multiple Sclerosis News Today

Atara Biotherapeutics has partnered with Imeka to use its proprietary biomarker imaging technology in the ongoing EMBOLD Phase 2 clinical trial, which is investigating ATA188 for the treatment of progressive ... Read more

January 13, 2022January 13, 2022

2 Trials to Test Oral BIIB122/DNL151 in Slowing Parkinson’s Progression

Parkinson's News Today

Biogen and Denali Therapeutics are planning to launch two late-stage clinical trials to further evaluate the potential of their investigational oral therapy BIIB122/DNL151 in treating people with Parkinson’s disease. The Phase 3 and ... Read more

January 11, 2022January 11, 2022

Award Granted to Support Research on Therapies to Fight Lung Bacteria

Cystic Fibrosis News Today

Peptilogics has won an award to conduct research for two antibacterial peptides as a first-line therapy to fight antibiotic-resistant bacteria in the lungs of people with cystic fibrosis (CF). According to ... Read more

January 11, 2022January 11, 2022

Declining Oral Health Affects Patients’ Life Quality, Study Suggests

Parkinson's News Today

Oral health affects life quality in adults with Parkinson’s, with oral health worsening with disease progression and resulting in a related greater decline in quality of life than is evident ... Read more

January 10, 2022January 11, 2022

Study to Assess Wellinks’ Digital Health Platform in Managing COPD

COPD News Today

Adults with chronic obstructive pulmonary disease (COPD) are being recruited for a study into whether Wellinks’ first integrated virtual management system solution for COPD can improve patient outcomes. The 24-week ... Read more

January 10, 2022January 10, 2022

PR3-ANCA Antibodies Tied to More Relapses in EGPA Patients

ANCA Vasculitis News

People with eosinophilic granulomatosis with polyangiitis (EGPA) who carry antibodies against the proteinase 3 (PR3) protein have more frequent relapses and a shorter time to relapse or death than patients ... Read more

January 10, 2022January 10, 2022

New Gene Mutation Linked to HAE Type 1 Identified in Spanish Family

Angioedema News

A new mutation in the SERPING1 gene linked to hereditary angioedema (HAE) type 1 was identified in three of five members of a Spanish family. Results were published in a letter to ... Read more

January 10, 2022January 10, 2022

Muscle MRI Scans May Help Check for Disease Progression, Study Says

FAP News Today

MRI scans of pelvis and leg muscles may serve as a marker of progression and treatment response in people with hereditary transthyretin (ATTRv) amyloidosis, a group of conditions that also ... Read more